SCIACQUA, Angela
 Distribuzione geografica
Continente #
NA - Nord America 3.962
EU - Europa 3.512
AS - Asia 1.901
SA - Sud America 215
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 8
Totale 9.641
Nazione #
US - Stati Uniti d'America 3.834
IT - Italia 2.298
SG - Singapore 1.405
DE - Germania 273
CN - Cina 237
NL - Olanda 203
SE - Svezia 191
GB - Regno Unito 180
BR - Brasile 172
FI - Finlandia 105
CA - Canada 99
IN - India 61
HK - Hong Kong 57
PL - Polonia 36
FR - Francia 33
ES - Italia 25
CZ - Repubblica Ceca 22
RU - Federazione Russa 22
EE - Estonia 21
RO - Romania 21
BD - Bangladesh 19
MX - Messico 18
IL - Israele 17
VN - Vietnam 16
UA - Ucraina 15
IR - Iran 13
GR - Grecia 12
IQ - Iraq 12
IE - Irlanda 11
TR - Turchia 11
ZA - Sudafrica 11
AT - Austria 10
CH - Svizzera 10
CL - Cile 10
JP - Giappone 10
EC - Ecuador 9
PE - Perù 9
PK - Pakistan 9
AU - Australia 7
EG - Egitto 7
TW - Taiwan 7
A2 - ???statistics.table.value.countryCode.A2??? 6
AL - Albania 6
AR - Argentina 6
CO - Colombia 5
AE - Emirati Arabi Uniti 4
ET - Etiopia 4
JM - Giamaica 4
MY - Malesia 4
UZ - Uzbekistan 4
BE - Belgio 3
GT - Guatemala 3
ID - Indonesia 3
KE - Kenya 3
MA - Marocco 3
NO - Norvegia 3
RS - Serbia 3
VE - Venezuela 3
EU - Europa 2
KR - Corea 2
KZ - Kazakistan 2
LT - Lituania 2
LY - Libia 2
MK - Macedonia 2
SA - Arabia Saudita 2
TN - Tunisia 2
AD - Andorra 1
AO - Angola 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CU - Cuba 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
HN - Honduras 1
HU - Ungheria 1
JO - Giordania 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
NG - Nigeria 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
Totale 9.641
Città #
Singapore 687
Chandler 634
Milan 371
Santa Clara 350
Princeton 219
Lawrence 218
Munich 214
Rome 187
Chicago 164
London 145
Ashburn 134
Wilmington 133
Boardman 108
Teverola 99
Aversa 86
Ottawa 69
Turku 68
Des Moines 57
Hong Kong 53
Turin 51
Naples 46
The Dalles 45
Los Angeles 43
Bari 42
Columbus 37
Helsinki 36
Palermo 36
Bologna 35
Catanzaro 34
Warsaw 32
Shanghai 31
New York 30
Norwalk 24
Assago 22
Florence 22
Olomouc 21
São Paulo 21
Genoa 19
Pune 18
Guangzhou 17
Hanover 16
San Francisco 16
Perugia 15
Reggio Emilia 15
Beijing 14
Brooklyn 13
Council Bluffs 13
Pescara 13
Redmond 13
Trieste 13
Charlotte 12
Chennai 12
Messina 12
Rende 12
Shenzhen 12
Verona 12
Bergamo 11
Boston 11
Padova 11
Phoenix 11
Redwood City 11
Dublin 10
Horia 10
Castrovillari 9
Cosenza 9
Monza 9
Paris 9
Tokyo 9
Vicenza 9
Amsterdam 8
Capaccio 8
Dongguan 8
Lima 8
Pisa 8
Reggio Calabria 8
Rio de Janeiro 8
Ankara 7
Atlanta 7
Brasília 7
Latina 7
Mexico City 7
Taranto 7
Torino 7
Udine 7
Vasto 7
Ancona 6
Ann Arbor 6
Athens 6
Buffalo 6
Cagliari 6
Dhaka 6
Dipignano 6
Houston 6
Johannesburg 6
Las Vegas 6
Livorno 6
Manchester 6
Montorso Vicentino 6
Mountain View 6
San Nicola Manfredi 6
Totale 5.209
Nome #
Harrison Principi di Medicina Interna, 19a Edizione 941
Citrus Bergamia and Cynara Cardunculus Reduce Serum Uric Acid in Individuals with Non-Alcoholic Fatty Liver Disease 723
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 86
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 75
Association of insulin resistance indexes to carotid intima-media thickness. 70
Increased carotid intima-media thickness in the physiologic range is associated with impaired postprandial glucose metabolism, insulin resistance and beta cell dysfunction 65
Positive association between plasma IGF1 and high-density lipoprotein cholesterol levels in adult nondiabetic subjects 62
Endothelial dysfunction and C-reactive protein are risk factors for diabetes in essential hypertension 58
Higher serum levels of uric acid are associated with a reduced insulin clearance in non-diabetic individuals 57
Role of a dual glucose-dependent insulinotropic peptide (GIP)/glucagon-like peptide-1 receptor agonist (twincretin) in glycemic control: From pathophysiology to treatment 55
Angiotensin II type 1 receptor, but no type 2 receptor, interferes with the insulin-induced nitric oxide production in HUVECs. 54
25a edizione del Goldman-Cecil Medicine 52
Association between hemoglobin glycation index and hepatic steatosis in non-diabetic individuals 52
Metabolic and cognitive effects of ranolazine in type 2 diabetes mellitus: Data from an in vivo model 51
Depressed myocardial mechano-energetic efficiency in subjects with dysglycemia 48
Sex-differences in insulin sensitivity and insulin secretion in subjects with impaired fasting glucose and impaired glucose tolerance 46
Ipopotassiemia e normotensione. Un caso di Sindrome di Gitelman 46
CHADS2 and CHA2DS2-VASc scores are independently associated with incident atrial fibrillation: the Catanzaro Atrial Fibrillation Project. 46
3'-UTR OLR1/LOX-1 gene polymorphism and endothelial dysfunction: molecular and vascular data in never-treated hypertensive patients 44
Competitive interaction between chronic obstructive pulmonary disease and CHA2DS2-VASc score in predicting incident atrial fibrillation 44
A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components 44
Circadian Clock Desynchronization and Insulin Resistance 43
Reciprocal association of plasma IGF-1 and interleukin-6 levels with cardiometabolic risk factors in nondiabetic subjects 43
Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease 43
Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension 43
Are Circulating Mg2+ Levels Associated with Glucose Tolerance Profiles and Incident Type 2 Diabetes? 43
Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells 43
Effects of a Functional Ice Cream Enriched with Milk Proteins on Bone Metabolism: A Feasibility Clinical Study and In Vitro Investigation 42
Decreased Pulse Wave Velocity in a Systemic Sclerosis Population: Preliminary Results from a Cross-Sectional Study 42
Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants. 42
Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals. 42
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with chronic kidney disease. 42
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity 42
Effects of Sacubitril-Valsartan on Clinical, Echocardiographic, and Polygraphic Parameters in Patients Affected by Heart Failure With Reduced Ejection Fraction and Sleep Apnea 41
Elevated 1-h post-load plasma glucose is associated with right ventricular morphofunctional parameters in hypertensive patients. 41
Weight loss in combination with physical activity improves endothelial dysfunction in human obesity 41
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy. 41
"Pattern citochinico, livelli circolanti di EPC e stiffness vascolare nell’ipertensione arteriosa essenziale" 41
Alkaline phosphatase affects renal function in never-treated hypertensive patients: effect modification by age 41
Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice 41
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia. 40
Association between serum Mg2+ concentrations and cardiovascular organ damage in a cohort of adult subjects 40
Characterization of left ventricular mass in individuals at risk for type 2 diabetes identified by HbA1c levels according to the American Diabetes Association criteria 40
Association Between Sleep Apnea and Valvular Heart Diseases 40
Short term effect of sacubitril/valsartan on comprehensive geriatric assessment in chronic heart failure: a real life analysis 39
One-hour post-load hyperglycemia combined with HbA1c identifies individuals with higher risk of cardiovascular diseases: Cross-sectional data from the CATAMERI study 39
Association between noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver disease 39
Low circulating insulin-like growth factor-1 levels are associated with high serum uric acid in nondiabetic adult subjects 39
Continuous Positive Airway Pressure Improves Renal Function in Obese Patients With Obstructive Sleep Apnea Syndrome 39
THE EFFECTS OF BATRIATIC SURGERY ON CARDIO-METABOLIC PROFILE AND CARDIAC REMODELING 39
Unfavorable inflammatory profile in adults at risk of type 2 diabetes identified by hemoglobin A1c levels according to the American Diabetes Association criteria 38
Asymmetric dimethylarginine plasma levels and endothelial function in newly diagnosed type 2 diabetic patients 38
Additive Effect of Non-Alcoholic Fatty Liver Disease on Metabolic Syndrome-Related Endothelial Dysfunction in Hypertensive Patients 38
Dieta Mediterranea e protezione vascolare 38
HDL cholesterol is an independent predictor of β-cell function decline and incident type 2 diabetes: A longitudinal study 38
Biologics in severe asthma 38
Depressed myocardial mechano-energetic efficiency in subjects with dysglycemia 38
Insulin-like growth factor-1 and glomerular filtration rate in hypertensive patients 37
IL DIABETE 37
Uric acid and vascular damage in essential hypertension: Role of insulin resistance 37
THE -866A/A GENOTYPE IN THE PROMOTER OF THE HUMAN UNCOUPLING PROTEIN 2 GENE IS ASSOCIATED WITH INSULIN RESISTANCE AND INCREASED RISK OF TYPE 2 DIABETES 36
Differences in insulin clearance between metabolically healthy and unhealthy obese subjects 36
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity. 36
Association between Noninvasive Fibrosis Markers and Cardio-Vascular Organ Damage among Adults with Hepatic Steatosis 36
EPCs CIRCULATING LEVELS IN ESSENTIAL HYPERTENSION 36
Association of hepatic insulin resistance indexes to nonalcoholic fatty liver disease and related biomarkers 35
ANGIOTENSIN II IMPAIRS THE INSULIN SIGNALING PATHWAY PROMOTING PRODUCTION OF NITRIC OXIDE BY INDUCING PHOSPHORYLATION OF IRS- 1 ON SER312 AND SER616 IN HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS 35
L’azione stimolatoria della leptina sulla produzione di ossido nitrico, mediata dalla via AMPKA11/AKT/ENOS, è bloccata dall’interazione con la PCR 35
Altered glucose metabolism and vascular function 35
Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease. 35
COVID-19 and elderly: beyond the respiratory drama 35
Ferritin modifies the relationship between inflammation and arterial stiffness in hypertensive patients with different glucose tolerance 35
Sarcopenia and Appendicular Muscle Mass as Predictors of Impaired Fasting Glucose/Type 2 Diabetes in Elderly Women 35
Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: The T.O.S.CA. Registry 35
IGF-1 levels link estimated glomerular filtration rate to insulin resistance in obesity: a study in obese, but metabolically healthy, subjects and obese, insulin-resistant subjects 34
SRT1720 counteracts glucosamine-induced endoplasmic reticulum stress and endothelial dysfunction 34
Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with unfavorable inflammatory profile. 34
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 34
One-hour post-load glucose levels are associated with hepatic steatosis assessed by transient elastography 33
Association between right ventricular dysfunction and adverse cardiac events in mild COPD patients 33
Insulin-like growth factor-1 (IGF-1) as predictor of cardiovascular mortality in heart failure patients: data from the T.O.S.CA. registry 33
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study. 33
Endothelial dysfunction, ADMA and insulin resistance in essential hypertension 33
Endothelial dysfunction and non-alcoholic liver steatosis in hypertensive patients 33
Laboratory diagnostics in the elderly: cardiovascular disease 33
Cardiometabolic risk profiles and carotid atherosclerosis in individuals with prediabetes identified by fasting glucose, postchallenge glucose, and hemoglobin A1c criteria 33
Different Patterns of Left Ventricular Hypertrophy in Metabolically Healthy and Insulin-Resistant Obese Subjects 33
One-hour post-load hyperglycemia is a stronger predictor of type 2 diabetes than impaired fasting glucose 33
Decreased insulin clearance in individuals with elevated 1-h post-load plasma glucose levels 33
Insulin clearance is associated with carotid artery intima-media thickness 32
One-hour post-load plasma glucose and IGF-1 in hypertensive patients. 32
Hemorheological alterations in adults with prediabetes identified by hemoglobin A1c levels. 32
A polymorphism at IGF1 locus is associated with carotid intima media thickness and endothelium-dependent vasodilatation. 32
Comparison of A1C, fasting and 2-h post-load plasma glucose criteria to diagnose diabetes in Italian Caucasians 32
One-hour post-load hyperglycemia confers higher risk of hepatic steatosis to HbA1c-defined pre-diabetic subjects 32
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry 32
Progressive right ventricular dysfunction and exercise impairment in patients with heart failure and diabetes mellitus: insights from the T.O.S.CA. Registry 31
Low-plasma insulin-like growth factor-I levels are associated with impaired endothelium-dependent vasodilatation in a cohort of untreated, hypertensive Caucasian subjects 31
“Caratterizzazione del pool di cellule progenitrici endoteliali mediante Citofluorimetria in pazienti con rischio cardiovascolare”. 31
Frequency of 1-h post-load glucose ≥155 mg/dl among individuals with different glucose tolerance conditions. 31
Totale 5.629
Categoria #
all - tutte 119.115
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.115


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021250 15 12 5 32 39 18 4 17 46 14 9 39
2021/2022794 10 9 14 139 98 11 35 149 94 119 97 19
2022/20232.034 457 43 75 168 224 170 83 180 269 124 172 69
2023/20241.710 217 154 117 117 111 238 93 235 54 88 110 176
2024/20254.593 467 177 159 183 339 483 232 327 706 230 500 790
2025/2026458 458 0 0 0 0 0 0 0 0 0 0 0
Totale 9.968